Insmed (INSM) PT Lowered to $162 at Evercore ISI
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $98.57 +2.89%
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
Evercore ISI analyst Gavin Clark-Gartner lowered the price target on Insmed (NASDAQ: INSM) to $162.00 (from $208.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ
- Venezuela oil export revenue rises 21.5% in first quarter
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
